Tech Company Financing Transactions
Vascular Pathways Funding Round
On 11/1/2010, Vascular Pathways raised $14 million in Series B funding from CHL Medical Partners, Arcus Ventures and Ascension Ventures.
Transaction Overview
Company Name
Announced On
11/1/2010
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Investors
Proceeds Purpose
The proceeds of the round will be used to commercialize the company's U.S. Food and Drug Administration cleared Rapid Intravascular Start (RIVS) IV catheter.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1847 Trade Center Way
Naples, FL 34109
USA
Naples, FL 34109
USA
Phone
Website
Email Address
Not Recorded
Overview
Vascular Pathways is a private medical devices company founded in 2005 involved in the commercialization of innovative vascular access devices. The AccuCath Intravenous Catheter System is an FDA cleared device enabling rapid, safe, and successful peripheral IV insertion.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bill Bold
VP - Manufacturing
Thomas Grifa
VP - Regulatory Affairs
Gina Gilbert
Browse more venture capital transactions:
Prev: 11/1/2010: The Rubicon Project venture capital transaction
Next: 11/1/2010: Vindicia venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs